SCHEMBL24796249

SCHEMBL24796249

CCC(OC(C)=O)c1noc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.39
MGLL Q99685 1/20 0.39
HIF1A Q16665 7/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TP53 P04637 3/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
MAOB P27338 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8664406 0.81 HIF1A (0.40) HIF1ASMN1; SMN2NPC1RAB9ATP53
SCHEMBL11208899 0.77 HIF1A (0.41) HIF1ASMN1; SMN2NPC1RAB9ATP53
SCHEMBL4983840 0.75 HIF1A (0.42) FAAHMGLLHIF1ASMN1; SMN2NPC1
SCHEMBL21658639 0.75 GRM4 (0.47) FAAHMGLLHIF1ASMN1; SMN2NPC1
SCHEMBL21976909 0.72 FAAH (0.43) FAAHMGLLHIF1ASMN1; SMN2NPC1
SCHEMBL20229553 0.72 FAAH (0.43) FAAHMGLLHIF1ASMN1; SMN2NPC1
SCHEMBL24796251 0.71 LMNA (0.44) FAAHMGLLHIF1ASMN1; SMN2NPC1
SCHEMBL7966160 0.71 FAAH (0.42) FAAHMGLLHIF1ASMN1; SMN2NPC1
SCHEMBL21976453 0.70 FAAH (0.44) FAAHMGLLSMN1; SMN2NPC1RAB9A
SCHEMBL890241 0.70 HIF1A (0.42) HIF1ASMN1; SMN2NPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535599-B2 Benzisoxazole derivative Sumitomo Pharma Co., Ltd. (JP) 2022-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11535599-B2 Benzisoxazole derivative HDAC3, GABRA5, HDAC2 FAAH 1628/4885MGLL 4094/4885HIF1A 2241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.